The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Plasma and tumor genomic correlates of response to BYL719 in PI3KCA mutated metastatic ER-positive breast cancer (ER+/HER2- BC).
 
Sarah-Jane Dawson
No Relationships to Disclose
 
Lironne Wein
No Relationships to Disclose
 
Maria Joao Silva
No Relationships to Disclose
 
Stephen James Luen
No Relationships to Disclose
 
Courtney VanGeelen
No Relationships to Disclose
 
Kate Moodie
No Relationships to Disclose
 
Peter Savas
No Relationships to Disclose
 
Chen-Fang Weng
No Relationships to Disclose
 
Andjelija Zivanovic Bujak
No Relationships to Disclose
 
Miriam M Yeung
No Relationships to Disclose
 
Sarah Ftouni
No Relationships to Disclose
 
Keilly Kuykhoven
No Relationships to Disclose
 
Rodney J Hicks
No Relationships to Disclose
 
Prudence A. Francis
Honoraria - AstraZeneca; Novartis
Travel, Accommodations, Expenses - Pfizer
 
Chee Khoon Lee
No Relationships to Disclose
 
Sherene Loi
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - PI3K pathway gene signature granted by the European and US patent offices (Inst)